10-[3-[4-[2-(1,3-ジオキサン-2-イル)エチル]-1-ピペラジニル]プロピル]-2-(トリフルオロメチル)-10H-フェノチアジン

10-[3-[4-[2-(1,3-ジオキサン-2-イル)エチル]-1-ピペラジニル]プロピル]-2-(トリフルオロメチル)-10H-フェノチアジン 化学構造式
16498-21-8
CAS番号.
16498-21-8
化学名:
10-[3-[4-[2-(1,3-ジオキサン-2-イル)エチル]-1-ピペラジニル]プロピル]-2-(トリフルオロメチル)-10H-フェノチアジン
别名:
10-[3-[4-[2-(1,3-ジオキサン-2-イル)エチル]-1-ピペラジニル]プロピル]-2-(トリフルオロメチル)-10H-フェノチアジン;オキサフルマジン;10-(3-{4-[2-(1,3-ジオキサン-2-イル)エチル]ピペラジン-1-イル}プロピル)-2-(トリフルオロメチル)-10H-フェノチアジン
英語名:
Oxaflumazine
英語别名:
SD 270-31;Oxaflumazine;Oxaflumazine D8;10-{3-[4-(2-[1,3]dioxan-2-yl-ethyl)-piperazin-1-yl]-propyl}-2-trifluoromethyl-10H-phenothiazine;10-[3-[4-[2-(1,3-Dioxan-2-yl)ethyl]-1-piperazinyl]propyl]-2-(trifluoromethyl)-10H-phenothiazine;10H-Phenothiazine, 10-[3-[4-[2-(1,3-dioxan-2-yl)ethyl]-1-piperazinyl]propyl]-2-(trifluoromethyl)-
CBNumber:
CB71179401
化学式:
C26H32F3N3O2S
分子量:
507.61
MOL File:
16498-21-8.mol

10-[3-[4-[2-(1,3-ジオキサン-2-イル)エチル]-1-ピペラジニル]プロピル]-2-(トリフルオロメチル)-10H-フェノチアジン 物理性質

沸点 :
605.5±55.0 °C(Predicted)
比重(密度) :
1.235±0.06 g/cm3(Predicted)
酸解離定数(Pka):
7.65±0.10(Predicted)

安全性情報

10-[3-[4-[2-(1,3-ジオキサン-2-イル)エチル]-1-ピペラジニル]プロピル]-2-(トリフルオロメチル)-10H-フェノチアジン 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

10-[3-[4-[2-(1,3-ジオキサン-2-イル)エチル]-1-ピペラジニル]プロピル]-2-(トリフルオロメチル)-10H-フェノチアジン 化学特性,用途語,生産方法

Originator

Oxaflumine, Diamant ,France,1970

Manufacturing Process

Preparation of N-(3-chloropropyl)-N'-[2-(1,3-dioxanyl)-ethyl]-piperazine: A solution of 30 g (0.15 mol) of N-[2-(1,3-dioxanyl)-ethyl]-piperazine and 11.8 g (0.075 mol) of 1-bromo-3-chloropropane in 150 ml of dry benzene was refluxed with stirring for 5 hours. After cooling, the N-[2-(1,3-dioxanyl)ethyl]-piperazinium bromide which had precipitated was filtered off, the filtrate was concentrated in vacuo and the residual oil was distilled. 14.1 g (68%yield) of N-(3-chloropropyl)-N'-[2-1,3-dioxanyl)-ethyl]-piperazine which occurred as a light yellow oil were obtained. Boiling point: 152°C to 155°C under 0.07 mm Hg (nD23 = 1.4940). The disuccinate prepared in acetone and recrystallized from acetone melts at 104°C to 105°C on a hot stage microscope.
The sodium derivative of the 2-trifluoromethylphenothiazine was prepared from 26.7 g (0.1 mol) of 2-trifluoromethylphenothiazine and 2.3 g (0.1 g atom) of sodium in 500 ml of liquid ammonia. After the reaction was completed, the ammonia was driven off and 500 ml of dry toluene were added. A solution of 25 g (0.09 mol) of N-(3-chloropropyl)-N'-[2-(1,3dioxanyl)-ethyl]-piperazine in 200 ml of toluene was added drop by drop to this solution which was then refluxed with stirring for 18 hours. After cooling, the precipitate which had formed was filtered and the filtrate was washed with water, dried and concentrated in vacuo. 33 g of brown oil, the N-3-(2trifluoromethyl-10-phenothiazinyl)-propyl-N'-2-[2-(1,3-dioxanyl)]-ethylpiperazine, were obtained.
A warm solution of 4.4 g of the base obtained in 100 ml of acetonitrile was added to a warm solution of succinic acid in 200 ml of acetonitrile. After standing for 15 hours at 0°C. the crystalline product was obtained, melting point 138°C.

Therapeutic Function

Neuroleptic, Antihistaminic, Spasmolytic

10-[3-[4-[2-(1,3-ジオキサン-2-イル)エチル]-1-ピペラジニル]プロピル]-2-(トリフルオロメチル)-10H-フェノチアジン 上流と下流の製品情報

原材料

準備製品


10-[3-[4-[2-(1,3-ジオキサン-2-イル)エチル]-1-ピペラジニル]プロピル]-2-(トリフルオロメチル)-10H-フェノチアジン 生産企業

Global( 4)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Alchem Pharmtech,Inc.
8485655694
sales@alchempharmtech.com United States 63711 58

16498-21-8(10-[3-[4-[2-(1,3-ジオキサン-2-イル)エチル]-1-ピペラジニル]プロピル]-2-(トリフルオロメチル)-10H-フェノチアジン)キーワード:


  • 16498-21-8
  • 10-[3-[4-[2-(1,3-Dioxan-2-yl)ethyl]-1-piperazinyl]propyl]-2-(trifluoromethyl)-10H-phenothiazine
  • SD 270-31
  • Oxaflumazine
  • 10-{3-[4-(2-[1,3]dioxan-2-yl-ethyl)-piperazin-1-yl]-propyl}-2-trifluoromethyl-10H-phenothiazine
  • 10H-Phenothiazine, 10-[3-[4-[2-(1,3-dioxan-2-yl)ethyl]-1-piperazinyl]propyl]-2-(trifluoromethyl)-
  • Oxaflumazine D8
  • 10-[3-[4-[2-(1,3-ジオキサン-2-イル)エチル]-1-ピペラジニル]プロピル]-2-(トリフルオロメチル)-10H-フェノチアジン
  • オキサフルマジン
  • 10-(3-{4-[2-(1,3-ジオキサン-2-イル)エチル]ピペラジン-1-イル}プロピル)-2-(トリフルオロメチル)-10H-フェノチアジン
Copyright 2017 © ChemicalBook. All rights reserved